GlassScriptPhysician profile
Paul T Cartwright
NPI 1932306149
$18,668.82
in general payments reported to CMS, 2019-2025
32 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $11K · 2021: $3,867 · 2022: $1,198 · 2023: $712 · 2024: $186 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130 · Travel and Lodging: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.20 |
| Travel and Lodging | $956.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,645.80 | 2019-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $1,044.90 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $307.59 | 2019-2025 | Phasix Mesh |
| Endogastric Solutions, INC | $227.16 | 2021-2022 | |
| Lucid Diagnostics INC. | $223.70 | 2022-2025 | |
| Ethicon US, LLC | $151.26 | 2019-2023 | Harmonic, Surgicel Nu-Knit |
| Medtronic, INC. | $149.04 | 2021 | |
| Integra Lifesciences Corporation | $109.25 | 2019-2022 | |
| Allergan, INC. | $76.60 | 2019-2022 | |
| Boston Scientific Corporation | $70.85 | 2019-2024 | |
| Olympus America INC. | $64.23 | 2023 | Visiglide, Endoclot Phs |
| Novo Nordisk INC | $62.98 | 2022-2023 | Wegovy |
| Rhythm Pharmaceuticals, INC. | $47.81 | 2023 | |
| Medical Device Business Services, INC. | $45.86 | 2023 | |
| Merck Sharp & Dohme LLC | $45.05 | 2024 | Keytruda |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $42.58 | 2021 | |
| Intra-Sana Laboratories | $33.14 | 2022 | |
| Baxter Healthcare | $32.45 | 2021-2022 | |
| Apollo Endosurgery US INC | $32.44 | 2023 | Overstitch Endoscopic Suturing System |
| Pentax of America, INC. | $30.74 | 2023 | |
| Kerecis Limited | $25.45 | 2022 | |
| Avanos Medical | $25.25 | 2021 | |
| Abbvie INC. | $22.32 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Conmed Corporation | $21.00 | 2022 | |
| Shire North American Group INC | $19.10 | 2019 | |
| Glaxosmithkline, LLC. | $18.32 | 2025 | Nucala |
| Pacira Pharmaceuticals Incorporated | $17.88 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.63 | 2024 | Gattex |
| Vertex Pharmaceuticals Incorporated | $16.63 | 2025 | |
| W. L. Gore & Associates, INC. | $15.49 | 2019 | |
| Asensus Surgical, INC. | $14.15 | 2019 | |
| Kci USA, INC. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Cartwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.